Fresh $18m fund injection for Singapore biotech firm doing Covid-19 research

SINGAPORE – Local biotech firm ImmunoScape has received a capital injection of US$14 million (S$18.7 million) to bring its total funding in the past year to US$25 million. Singapore’s EDBI, the …
( read original story …)


Search your Hotel